Status:
TERMINATED
Evaluation of Ocular Lens Proteins in Cataract From Individuals With Down Syndrome
Lead Sponsor:
University of Colorado, Denver
Collaborating Sponsors:
Children's Hospital Colorado
Conditions:
Cataract
Down Syndrome
Eligibility:
All Genders
1-18 years
Brief Summary
This study involves the collection ocular lens tissue from individuals with Down syndrome and age-matched controls at the time of cataract surgery.
Detailed Description
Individuals with Down syndrome have an increased rate of cataract. The reason for this increase is unclear. Normally, once cataracts become a significant impairment, an ophthalmologist will determine ...
Eligibility Criteria
Inclusion
- Undergoing cataract surgery for lens extraction.
Exclusion
- Known genetic cause other than Down syndrome causing cataract.
Key Trial Info
Start Date :
May 30 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2020
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT03778528
Start Date
May 30 2018
End Date
July 1 2020
Last Update
July 7 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital of Colorado
Aurora, Colorado, United States, 80045